Literature DB >> 23934711

Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival.

Jessica Gabler1, Jürgen Wittmann, Martina Porstner, Harald Renz, Hans-Martin Jäck, Melanie Abram, Michael Zemlin.   

Abstract

Plasma cells can survive for long periods and continuously secrete protective antibodies, but plasma cell production of autoantibodies or transformation to tumor cells is detrimental. Plasma cell survival depends on exogenous factors from the surrounding microenvironment, and largely unknown intracellular mediators that regulate cell homeostasis. Here we investigated the contribution of the microRNA 24-3p (miR-24-3p) to the survival of human plasma cells under the influence of IL-6 and SDF-1α (stromal cell derived factor 1), both of which are bone marrow survival niche mediators. Deep sequencing revealed a strong expression of miR-24-3p in primary B cells, plasma blasts, plasma cells, and in plasmacytoma cells. In vitro studies using primary cells and the plasmacytoma cell line RPMI-8226 revealed that (i) expression of miR-24-3p mediates plasma cell survival, (ii) miR-24-3p is upregulated by IL-6 and SDF-1α, (iii) IL-6 mediates cell survival under ER stress conditions via miR-24-3p expression, and (iv) IL-6-induced miR-24-3p expression depends on the activity of the MAP kinase Erk1/2. These results suggest a direct connection between an external survival signal and an intracellular microRNA in regulating plasma cell survival. miR-24-3p could therefore be a promising target for new therapeutic strategies for autoimmune and allergic diseases and for multiple myeloma.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Erk1/2; Interleukin-6; MicroRNA-24-3p; Plasma cells; Survival

Mesh:

Substances:

Year:  2013        PMID: 23934711     DOI: 10.1002/eji.201243271

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Development and Validation of a MicroRNA Panel to Differentiate Between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.

Authors:  Michelle J Ormseth; Joseph F Solus; Quanhu Sheng; Fei Ye; Qiong Wu; Yan Guo; Annette M Oeser; Ryan M Allen; Kasey C Vickers; C Michael Stein
Journal:  J Rheumatol       Date:  2019-05-15       Impact factor: 4.666

Review 2.  Plasma cells in immunopathology: concepts and therapeutic strategies.

Authors:  Benjamin Tiburzy; Upasana Kulkarni; Anja Erika Hauser; Melanie Abram; Rudolf Armin Manz
Journal:  Semin Immunopathol       Date:  2014-04-17       Impact factor: 9.623

3.  Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.

Authors:  Michelle J Ormseth; Joseph F Solus; Kasey C Vickers; Annette M Oeser; Paolo Raggi; C Michael Stein
Journal:  J Rheumatol       Date:  2015-08-01       Impact factor: 4.666

Review 4.  The Maintenance of Memory Plasma Cells.

Authors:  Laleh Khodadadi; Qingyu Cheng; Andreas Radbruch; Falk Hiepe
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

5.  Herpes simplex virus 1 evades cellular antiviral response by inducing microRNA-24, which attenuates STING synthesis.

Authors:  Nikhil Sharma; Chenyao Wang; Patricia Kessler; Ganes C Sen
Journal:  PLoS Pathog       Date:  2021-09-30       Impact factor: 7.464

6.  A comparative study of adjuvants effects on neonatal plasma cell survival niche in bone marrow and persistence of humoral immune responses.

Authors:  Audur Anna Aradottir Pind; Sigrun Thorsdottir; Gudbjorg Julia Magnusdottir; Andreas Meinke; Giuseppe Del Giudice; Ingileif Jonsdottir; Stefania P Bjarnarson
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

7.  ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.

Authors:  Dandan Yu; Yali Zhong; Xiaoran Li; Yaqing Li; Xiaoli Li; Jing Cao; Huijie Fan; Yuan Yuan; Zhenyu Ji; Baoping Qiao; Jian-Guo Wen; Mingzhi Zhang; Gunnar Kvalheim; Jahn M Nesland; Zhenhe Suo
Journal:  Oncotarget       Date:  2015-12-15

8.  MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.

Authors:  Manjistha Sengupta; Bi-Dar Wang; Norman H Lee; Alexander Marx; Linda L Kusner; Henry J Kaminski
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

9.  miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT.

Authors:  Pengyu Jing; Nianlin Xie; Nan Zhao; Ximing Zhu; Pei Li; Guizhou Gao; Haizhou Dang; Zhongping Gu
Journal:  J Immunol Res       Date:  2020-04-28       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.